---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-018883"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2023-05-24T23:59:59+00:00"
generated_at: "2026-06-14T15:57:26.728229+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Processa Pharma presents at World Orphan Drug Congress on Project Optimus for rare cancers

## Summary
- Dr. David Young participates in panel titled 'Clinical Development & Regulatory Panel Session: Patient focused drug development' at World Orphan Drug Congress on May 24, 2023.
- Also presents Pitch and Partner presentation titled 'Applying FDA’s Project Optimus to the Next Generation of Chemotherapy Drugs Treating Rare Cancers' at 1:00 PM ET.
- Presentation made available in Investors section of company website; detailed content not disclosed in this filing.

## SEC filing metadata
- accession: 0001493152-23-018883
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2023-05-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315223018883/0001493152-23-018883-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315223018883/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-018883
- JSON: https://secwatch.observer/filing/0001493152-23-018883.json
- Plain text: https://secwatch.observer/filing/0001493152-23-018883.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.